Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

Stopped early

Conditions studied: Keratoconus, Ectasia, Degeneration

In brief

The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication. The data generated by this study will not be submitted to the FDA to support commercialization of these riboflavin drops.

Key facts

Study ID
NCT01189864
Run by
Cxlusa
People needed
3493
Starts
2010-02-01
Expected to finish
2017-02-03
Last updated by the study team
2018-10-12

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.